BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 21907924)

  • 21. Progeny of Olig2-expressing progenitors in the gray and white matter of the adult mouse cerebral cortex.
    Dimou L; Simon C; Kirchhoff F; Takebayashi H; Götz M
    J Neurosci; 2008 Oct; 28(41):10434-42. PubMed ID: 18842903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Developmental and post-injury cortical gliogenesis: a genetic fate-mapping study with Nestin-CreER mice.
    Burns KA; Murphy B; Danzer SC; Kuan CY
    Glia; 2009 Aug; 57(10):1115-29. PubMed ID: 19115384
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NG2-expressing cells as oligodendrocyte progenitors in the normal and demyelinated adult central nervous system.
    Polito A; Reynolds R
    J Anat; 2005 Dec; 207(6):707-16. PubMed ID: 16367798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age-dependent fate and lineage restriction of single NG2 cells.
    Zhu X; Hill RA; Dietrich D; Komitova M; Suzuki R; Nishiyama A
    Development; 2011 Feb; 138(4):745-53. PubMed ID: 21266410
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Properties and fate of oligodendrocyte progenitor cells in the corpus callosum, motor cortex, and piriform cortex of the mouse.
    Clarke LE; Young KM; Hamilton NB; Li H; Richardson WD; Attwell D
    J Neurosci; 2012 Jun; 32(24):8173-85. PubMed ID: 22699898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transduction of extracellular cues into cell polarity: the role of the transmembrane proteoglycan NG2.
    Binamé F
    Mol Neurobiol; 2014 Oct; 50(2):482-93. PubMed ID: 24390567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clonal analysis for elucidating the lineage potential of embryonic NG2+ cells.
    Ju PJ; Liu R; Yang HJ; Xia YY; Feng ZW
    Cytotherapy; 2012 May; 14(5):608-20. PubMed ID: 22277011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crucial role of the local micro-environment in fate decision of neonatal rat NG2 progenitors.
    Sypecka J; Sarnowska A; Domanska-Janik K
    Cell Prolif; 2009 Oct; 42(5):661-71. PubMed ID: 19614677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Unbiased stereological analysis of the fate of oligodendrocyte progenitor cells in the adult mouse brain and effect of reference memory training.
    Boulanger JJ; Messier C
    Behav Brain Res; 2017 Jun; 329():127-139. PubMed ID: 28442356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of p27Kip1 function results in increased proliferative capacity of oligodendrocyte progenitors but unaltered timing of differentiation.
    Casaccia-Bonnefil P; Hardy RJ; Teng KK; Levine JM; Koff A; Chao MV
    Development; 1999 Sep; 126(18):4027-37. PubMed ID: 10457012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NG2 cells generate oligodendrocytes and gray matter astrocytes in the spinal cord.
    Zhu X; Hill RA; Nishiyama A
    Neuron Glia Biol; 2008 Feb; 4(1):19-26. PubMed ID: 19006598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multipotency and therapeutic potential of NG2 cells.
    Valny M; Honsa P; Kriska J; Anderova M
    Biochem Pharmacol; 2017 Oct; 141():42-55. PubMed ID: 28522408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NG2 cells in the brain: a novel glial cell population.
    Nishiyama A
    Hum Cell; 2001 Mar; 14(1):77-82. PubMed ID: 11436356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early postnatal proteolipid promoter-expressing progenitors produce multilineage cells in vivo.
    Guo F; Ma J; McCauley E; Bannerman P; Pleasure D
    J Neurosci; 2009 Jun; 29(22):7256-70. PubMed ID: 19494148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytology and lineage of NG2-positive glia.
    Berry M; Hubbard P; Butt AM
    J Neurocytol; 2002; 31(6-7):457-67. PubMed ID: 14501216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of oligodendrocyte progenitor cell antigens by gliomas: implications for the histogenesis of brain tumors.
    Shoshan Y; Nishiyama A; Chang A; Mörk S; Barnett GH; Cowell JK; Trapp BD; Staugaitis SM
    Proc Natl Acad Sci U S A; 1999 Aug; 96(18):10361-6. PubMed ID: 10468613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The NG2 proteoglycan: past insights and future prospects.
    Stallcup WB
    J Neurocytol; 2002; 31(6-7):423-35. PubMed ID: 14501214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NG2-positive cells generate A2B5-positive oligodendrocyte precursor cells.
    Baracskay KL; Kidd GJ; Miller RH; Trapp BD
    Glia; 2007 Aug; 55(10):1001-10. PubMed ID: 17503442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The response of NG2-expressing oligodendrocyte progenitors to demyelination in MOG-EAE and MS.
    Reynolds R; Dawson M; Papadopoulos D; Polito A; Di Bello IC; Pham-Dinh D; Levine J
    J Neurocytol; 2002; 31(6-7):523-36. PubMed ID: 14501221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The GPR17 receptor in NG2 expressing cells: focus on in vivo cell maturation and participation in acute trauma and chronic damage.
    Boda E; Viganò F; Rosa P; Fumagalli M; Labat-Gest V; Tempia F; Abbracchio MP; Dimou L; Buffo A
    Glia; 2011 Dec; 59(12):1958-73. PubMed ID: 21956849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.